HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven Pipe, MD
University of Michigan
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cliniques Universitaires Saint-Luc
Brussels, Belgium
- University Hospital Leuven
Leuven, Belgium
- Righospitalet
Copenhagen, Denmark
- Vivantes Klinikum Im Friedrichshain
Berlin, Germany
- Klinikum Der Johann Wolfgang Goethe Universitat
Frankfurt am Main, Germany
- National Coagulation Centre, St James'S Hospital
Dublin, Ireland
- Amsterdam Umc - Locatie Amc
Amsterdam, Netherlands
- Universitair Medisch Centrum Groningen
Groningen, Netherlands
- Erasmus Mc
Rotterdam, Netherlands
- Umc Utrecht, Van Creveldkliniek
Utrecht, Netherlands
- Center for Thrombosis and Hemostasis Skåne University Hospital Malmö
Malmö, Sweden
- the Cambridge Haemophilia and Thrombophilia Centre Camridge University Hospitals Nhs Foundation Trust - Box 217 Addenbrooke'S Hospital
Cambridge, United Kingdom
- the Royal London Hospital (barts Health Nhs Trust)
London, United Kingdom
- University Hospital Southampton Nhs Foundation Trust
Southampton, United Kingdom
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- Los Angeles Orthopedic Hospital
Los Angeles, California, United States
- University of California, Davis
Sacramento, California, United States
- University of California, San Diego
San Diego, California, United States
- University of Colorado Denver
Aurora, Colorado, United States
- Children'S National Medical Center Hematology and Oncology
Washington D.C., District of Columbia, United States
- University of South Florida
Tampa, Florida, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Hemophilia Center of Western New York
Buffalo, New York, United States
- University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Tennessee Health Science Center
Memphis, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Texas Health Science Center & Medical School
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Bloodworks Northwest
Seattle, Washington, United States
- Washington Institute for Coagulation
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Jun 2018
- Primary completion
- 22 Sept 2021
- Completion
- 19 Mar 2025
- Last update posted
- 27 Mar 2026
- Registered enrollment
- 67
- Registry id
- NCT03569891
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.